The purpose. To form prospects for the development of the pharmacovigilance system in pediatrics through the study and analysis of the structure of adverse drug reactions among children and adolescents. Materials and methods. There were used common science theoretical methods (system analysis, generalization and systems approach); bibliographic method (elaboration of scientific related literature on topic). Results. The hospitalizations frequency among pediatric patients due to complications of pharmacotherapy is being actively studied abroad. In the Czech Republic, among other countries, the frequency of children and adolescents inpatient care due to the development of drug adverse reactions (hereafter – ADRs) is 2,2 %, in the UK – 4 %, in Iran – 4,1 %. This number ranges from 0,4 % to 10,3 % worldwide. Among the drugs that most often lead to the development of ADRs in children and adolescents, most authors include vaccines and antimicrobial drugs, in particular, penicillin antibiotics. Among the side effects of drugs, the most common reason of seeking for medical help were complications which develop after β-lactam antibiotics use. The second place in the structure of drugs, the reception of which is accompanied with the development of ADRs, is occupied mainly by drugs for the treatment of diseases of the nervous system, in particular anticonvulsants. Conclusion. It has been found that the safety of drugs for children is often limited and controversial in terms of age, so marketing surveillance is fundamental, as it is often the only reliable method of first assessing the safety of drugs, especially when side effects are rare and require large samples for their detection. The distribution of adverse reactions among middle-aged adolescents is dominated by skin syndromes or general disorders of the body on average about 30%, and 15-19 percent are disorders of the gastrointestinal tract or central and peripheral nervous system disorders. It is shown that almost a third of hospitalized children and up to 90% of infants maintain drugs illegally, and this, in turn, need the proper development of pharmacovigilance in pediatrics, which should be able to rely on adequate infrastructure based on electronic networks, forming regional cooperation partnerships.